Skip to the content
Please enable JavaScript in your browser to complete this form.
REGISTRATION FORM
*
Mandatory field
Country/Region
*
Please select
Australia
Indonesia
Malaysia
Singapore
Taiwan
Thailand
Vietnam
Other
Country / Region_Others
*
Title
*
Please select
Prof
Dr
Mr
Mrs
Ms
Other
Title_Other
*
First Name
*
Last Name
*
Email
*
Hospital/Institution
*
Specialty
*
Please select
Oncology
Pathology
Pulmonology
Thoracic Surgery
Other
Specialty_Other
*
National ID Number/Membership Number for Taiwan Lung Cancer Society
By filling in this form and ticking this box, you (a) agree and accept Roche’s Legal Statement AND (b) consent to the collection and processing of your personal data in accordance with Roche's Privacy Notice.
*
By filling in this form and ticking this box, you (a) agree and accept Roche’s
Legal Statement
AND (b) consent to the collection and processing of your personal data in accordance with Roche's
Privacy Notice
.
*
Please tick this box to subscribe to upcoming webinars, news, and information about Roche’s services, and events ("Updates”).
Please tick this box to subscribe to upcoming webinars, news, and information about Roche’s services, and events ("Updates”).
Next
PRE-MEETING SURVEY
*
Mandatory field
1 What is your preferred first-line treatment for patients with ES-SCLC?
*
Atezolizumab + Chemotherapy
Durvalumab + Chemotherapy
Chemotherapy
Palliative care
Other (please specify)
1_other
*
1.1 Based on your answer above, what is the main reason for choosing this regimen?
2 For ES-SCLC patients with brain metastases, what is your preferred first-line treatment?
*
Atezolizumab + Chemotherapy
Durvalumab + Chemotherapy
Chemotherapy
Palliative care
Other (please specify)
2_other
*
2.1 Based on your answer above, what is the main reason for choosing this regimen?
3 For fragile patients (e.g., elderly, ECOG 2+), what is your preferred first-line treatment?
*
Atezolizumab + Chemotherapy
Durvalumab + Chemotherapy
Chemotherapy
Palliative care
Other (please specify)
3_other
*
3.1 Based on your answer above, what is the main reason for choosing this regimen?
Submit
